Profiel
Peter DiRoma is a professional with experience in regulatory affairs and quality assurance.
He is currently the Senior VP-Regulatory, Quality & Government Affairs at Ra Pharmaceuticals, Inc. Prior to this, he held positions as Vice President-Regulatory Affairs at Merck KGaA, EMD Serono, Inc., and Vice President-Global Regulatory Affairs at Dendreon Corp.
He also served as Senior VP-Regulatory Affairs & Quality Assurance at Melinta Therapeutics, Inc. and VP-Regulatory Affairs & Quality Assurance at Melinta Subsidiary Corp.
Mr. DiRoma received his undergraduate degree from the University of South Florida.
Actieve functies van Peter DiRoma
| Bedrijven | Functie | Begin |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-11-2018 |
Eerdere bekende functies van Peter DiRoma
| Bedrijven | Functie | Einde |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Algemeen Adviseur | 01-09-2018 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Algemeen Adviseur | - |
| MERCK KGAA | Algemeen Adviseur | - |
| DENDREON CORPORATION | Algemeen Adviseur | - |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Algemeen Adviseur | - |
Opleiding van Peter DiRoma
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
















